KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $1.0 billion.

  • West Pharmaceutical Services' Total Non-Current Liabilities rose 1333.85% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 1333.85%. This contributed to the annual value of $1.0 billion for FY2025, which is 1333.85% up from last year.
  • According to the latest figures from Q4 2025, West Pharmaceutical Services' Total Non-Current Liabilities is $1.0 billion, which was up 1333.85% from $979.0 million recorded in Q3 2025.
  • In the past 5 years, West Pharmaceutical Services' Total Non-Current Liabilities ranged from a high of $1.0 billion in Q4 2025 and a low of $812.1 million during Q3 2022
  • For the 5-year period, West Pharmaceutical Services' Total Non-Current Liabilities averaged around $895.1 million, with its median value being $886.2 million (2021).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 2318.86% in 2021, then plummeted by 1100.27% in 2022.
  • Over the past 5 years, West Pharmaceutical Services' Total Non-Current Liabilities (Quarter) stood at $940.2 million in 2021, then decreased by 6.37% to $880.3 million in 2022, then rose by 1.1% to $890.0 million in 2023, then increased by 1.0% to $898.9 million in 2024, then grew by 13.34% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q4 2025, $979.0 million for Q3 2025, and $953.3 million during Q2 2025.